Bioventus Inc.
Bioventus Inc. (BVS) Stock Overview
Explore Bioventus Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
436M
P/E Ratio
-13.77
EPS (TTM)
$-0.48
ROE
-0.21%
BVS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Bioventus Inc. (BVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 47.09, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $21.96.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -13.77 and a market capitalization of 436M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.